+33 (0)251 252 000 contact@inflectisbioscience.com

Philippe Guédat, PhD, Co-founder

Phillippe Guedate, PhD

Philippe Guédat, PhD
Co-Founder

Dr Philippe Guédat has over 20 years of experience in drug discovery in the industry. Philippe held positions of responsibility in the “business units”. He was the Director of Chemistry at Hybrigenics and the head of the drug discovery department at Vivalis (now Valneva). His expertise ranges from the discovery of chemical molecules with the implementation of high-throughput screening platforms to clinical development of drug candidates. Medicinal chemist by training, he optimized many chemical series in a variety of therapeutic areas and filed more than 20 patent families. He has been a consultant for several biopharmaceutical companies and “reviewer” for scientific journals. He is the author of 18 scientific publications.

Philippe has a Master’s degree in medicinal chemistry and pharmacology, a Master’s degree of supramolecular organic chemistry and a PhD in medicinal chemistry and pharmacology from the University Louis Pasteur (Strasbourg). Philippe worked at the University of Cambridge (UK), SmithKline Beecham (UK), Merck-Serono, Hybrigenics and Vivalis (now Valneva). In 2013, he co-founded InFlectis BioScience where he has been acting as President and Chief Executive Officer until end of February 2024.